Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Nastasi

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide Capodanno
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide Capodanno
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Pageof 1